COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences (NASDAQ:COGT) was upgraded by analysts at Wall Street
Cogent Biosciences (NASDAQ:COGT) had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $67.00. They now have an "overweight" rating on the stock.
Cogent Biosciences: Time For A Pause [Seeking Alpha]
Cogent Biosciences (NASDAQ:COGT) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Cogent Biosciences (NASDAQ:COGT) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Form 4 Cogent Biosciences, Inc. For: Dec 17 Filed by: Kearns Evan
Form 4 Cogent Biosciences, Inc. For: Dec 17 Filed by: Robinson John Edward
Form 4 Cogent Biosciences, Inc. For: Dec 17 Filed by: Pinnow Cole
Form 4 Cogent Biosciences, Inc. For: Dec 17 Filed by: Green John L.
Form 4 Cogent Biosciences, Inc. For: Dec 17 Filed by: Robbins Andrew R
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.